Safety and Efficacy of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Candidemia
Latest Information Update: 05 Nov 2023
At a glance
- Drugs Interferon gamma-1b (Primary) ; Antifungals
- Indications Candidaemia; Invasive candidiasis
- Focus Therapeutic Use
- 14 Mar 2022 Planned initiation date changed from 1 Jan 2022 to 15 Mar 2022.
- 14 Mar 2022 Status changed from not yet recruiting to recruiting.
- 01 Dec 2021 Planned End Date changed from 1 Dec 2024 to 1 Jan 2025.